FIGURE 1.

FIGURE 2.

FIGURE 3.

MRI quantitative parameters for molecular subtypes of breast cancer
| Parameters | Luminal A (n = 52) | Luminal B (n = 135) | HER2-enriched (n = 31) | TNBC (n = 45) | p |
|---|---|---|---|---|---|
| T1 SIR | 1.318 (1.179–1.630) | 1.366 (1.209–1.620) | 1.515 (1.268–1.788) | 1.254 (1.141–1.401) | 0.026 |
| T2 SIR | 3.137±1.156 | 3.163±1.186 | 3.280±1.289 | 3.689±1.093 | 0.009 |
| Mean ADC (×10−3 mm2/s) | 1.037±0.291 | 0.912±0.211 | 1.102±0.297 | 0.900±0.164 | 0.000 |
| Tumor diameter (cm) | 1.200 (0.887–1.762) | 1.900 (1.325–2.725) | 1.150 (0.600–2.750) | 2.550 (1.700–3.750) | 0.000 |
Clinical characteristics of patients and MRI morphological features for different molecular subtypes
| Parameters | Luminal A (n = 52) | Luminal B (n = 135) | HER2-enriched (n = 31) | TN (n = 45) | p |
|---|---|---|---|---|---|
| ALNM | 0.010 | ||||
| Yes | 9 (17.3) | 58 (43.0) | 12 (38.7) | 14 (31.1) | |
| No | 43 (82.7) | 77 (57.0) | 19 (61.3) | 31 (68.9) | |
| History of hormone use | 0.038 | ||||
| Yes | 3 (5.8) | 2 (1.5) | 3 (9.7) | 0 (0.0) | |
| No | 49 (94.2) | 133 (98.5) | 28 (90.3) | 45 (100.0) | |
| Tumor morphology | 0.053 | ||||
| Mass | 43 (82.7) | 114 (84.4) | 20 (64.5) | 39 (86.7) | |
| Non-mass | 9 (17.3) | 21 (15.6) | 11 (35.5) | 6 (13.3) | |
| Margin | 0.206 | ||||
| Circumscribed | 21 (40.4) | 39 (28.9) | 13 (41.9) | 19 (42.2) | |
| Not-circumscribed | 31 (59.6) | 96 (71.1) | 18 (58.1) | 26 (57.8) | |
| Dynamic curve curve | 0.248 | ||||
| type I | 8 (15.4) | 13 (9.6) | 4 (12.9) | 7 (15.6) | |
| type II | 9 (17.3) | 30 (22.2) | 12 (38.7) | 8 (17.8) | |
| type III | 35 (67.3) | 92 (68.1) | 15 (48.4) | 30 (66.7) |
ROC analysis of MRI quantitative parameters for separating one subtype from all other subtypes
| Parameters | AUC | Cutoff value | Sensitivity (%) | Specificity (%) | p* |
|---|---|---|---|---|---|
| Luminal A vs. all others | |||||
| T1 SIR | 0.506 | ≤ 1.270 | 46.15 (40.1, 52.2) | 61.61 (55.7, 67.5) | 0.640 |
| T2 SIR | 0.550 | ≤ 3.000 | 59.62 (53.7, 65.6) | 54.50 (48.5, 60.5) | 0.397 |
| Mean ADC (×10−3 mm2/s) | 0.612 | > 0.980 | 46.15 (40.3, 52.0) | 70.62 (65.3, 76.0) | 0.022 |
| Tumor diameter(cm) | 0.768 | ≤l.900 | 80.00 (73.1, 86.9) | 64.2 (57.0, 71.4) | 0.016 |
| Luminal B vs. all others | |||||
| T1 SIR | 0.510 | >1.291 | 62.96 (56.2, 69.7) | 48.44 (41.7, 55.2) | 0.181 |
| T2 SIR | 0.563 | ≤ 3.298 | 65.93 (59.6, 72.3) | 45.31 (38.6, 52.0) | 0.169 |
| Mean ADC (×10−3 mm2/s) | 0.624 | ≤ 0.978 | 77.78 (71.6, 84.0) | 44.53 (37.8, 51.3) | 0.012 |
| Tumor diameter(cm) | 0.540 | >1.550 | 78.63 (71.7, 85.6) | 35.58 (28.2, 42.9) | 0.829 |
| HER2-enriched vs. all others | |||||
| T1 SIR | 0.631 | > 1.503 | 58.06 (50.3, 65.8) | 69.40 (61.9, 76.9) | 0.000 |
| T2 SIR | 0.517 | > 2.815 | 67.74 (60.0, 75.5) | 44.40 (36.6, 52.2) | 0.927 |
| Mean ADC (×10−3 mm2/s) | 0.713 | > 0.903 | 87.10 (81.5, 92.7) | 53.02 (45.1, 60.9) | 0.002 |
| Tumor diameter(cm) | 0.543 | > 2.190 | 60.00 (52.4, 67.6) | 60.20 (52.6, 67.8) | 0.697 |
| TN vs. all others | |||||
| T1 SIR | 0.608 | ≤ 1.286 | 64.44 (58.6, 70.2) | 62.84 (57.0, 68.7) | 0.176 |
| T2 SIR | 0.655 | >3.157 | 68.89 (61.8, 76.0) | 59.63 (51.9, 67.4) | 0.020 |
| Mean ADC (×10−3 mm2/s) | 0.562 | ≤ 0.869 | 51.11 (44.1, 58.1) | 62.39 (54.9, 69.9) | 0.087 |
| Tumor diameter(cm) | 0.706 | >2.050 | 74.36(65.3, 83.4) | 57.69 (49.3, 66.1) | 0.040 |
Intraclass correlation coefficient (ICC) analysis between the two readers
| Parameters | ICC (95%CI) |
|---|---|
| T1 SIR | 0.970 (0.961–0.976) |
| T2 SIR | 0.967 (0.957–0.974) |
| Mean ADC (×10−3 mm2/s) | 0.898 (0.871–0.919) |
| Tumor diameter (cm) | 0.923 (0.900–0.940) |
ROC analysis of combined parameters for separating one subtype from all other subtypes
| AUC | Sensitivity (%) | Specificity (%) | p | |
|---|---|---|---|---|
| Luminal A vs. all others | ||||
| Mean ADC+ tumor diameter | 0.781 | 82.22 (76.57, 87.87) | 74.43 (68.99, 79.87) | < 0.001 |
| Luminal B vs. all others | ||||
| Mean ADC+ALNM | 0.639 | 62.96 (57.12, 68.80) | 60.94 (55.04, 66.84) | < 0.001 |
| HER2-enriched vs. all others | ||||
| T1 SIR + mean ADC+ non-mass | 0.728 | 38.71(21.56, 55.86) | 94.4(91.44, 97.36) | < 0.001 |
| TN vs. all others | ||||
| T2SIR+ tumor diameter | 0.724 | 89.74 (85.64, 93.84) | 52.20 (45.68, 58.72) | 0.002 |